Study of Rehabilitation Therapy on Patients After Acute Myocardial Infarction
Not Applicable
- Conditions
- Acute Myocardial Infarction
- Registration Number
- NCT00725088
- Lead Sponsor
- Ministry of Science and Technology of the People´s Republic of China
- Brief Summary
The purpose of this study is to determine whether exercise rehabilitation can reduce mortality, reinfarction or heart failure of patients after acute myocardial infarction.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
- Clinical diagnosis of ST-elevated myocardial infarction
- Heart function class I-II(killip classification)
- Agree to take cardiopulmonary exercise testing before discharge
- Signature of the informed consent document
Exclusion Criteria
- History of myocardial infarction
- Acute myocardial infarction with severe complications(such as pulmonary edema, severe cardiac arrhythmia or cardiogenic shock)
- Atrial fibrillation
- Other severe diseases, such as HIV infection, malignant tumor or chronic diseases of liver, kidney or pulmonary
- Not be capable of exercise training
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Cardiac mortality one year
- Secondary Outcome Measures
Name Time Method Non-fatal reinfarction, revascularization(PCI/CABG), ischemic stroke, unstable angina pectoris needs for hospitalization, severe heart failure needs for hospitalization one year
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways does exercise rehabilitation modulate to reduce post-AMI mortality in NCT00725088?
How does structured exercise training compare to standard care in preventing reinfarction and heart failure after AMI?
Which biomarkers (e.g., BNP, troponin) predict response to cardiac rehab in NCT00725088 participants?
What adverse events (e.g., arrhythmias, ischemia) are associated with post-AMI exercise protocols in NCT00725088?
Are there combination therapies with pharmacological agents (e.g., beta-blockers) enhancing exercise rehab outcomes in AMI patients?
Trial Locations
- Locations (1)
Peking University Third Hospital
🇨🇳Beijing, Beijing, China
Peking University Third Hospital🇨🇳Beijing, Beijing, China